By increasing the availability of CFTR channels at the cell surface, correctors lay the groundwork for potentiators, which subsequently enhance channel activity, working in synergy to restore CFTR function and mitigate the defects associated with CF. This evidence concerns the gene CFTR and cystic fibrosis.